HEIDI ODUM: Open Payments
NPI 1730814260 · MANCHESTER, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$140 in 7 payments from 6 companies in 2025. Trend: 2023 $871 · 2024 $525 · 2025 $140
Food & beverage: $140
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 2 | $38 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $29 |
| Lilly USA, LLC | 1 | $26 |
| Fresenius USA Marketing, Inc. | 1 | $17 |
| Travere Therapeutics, Inc. | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: Fabhalta, Kerendia, JARDIANCE, VELPHORO, LOKELMA.
Industry payments across NH — which companies pay providers there.
